Delphia (USA)’s Alkermes ALKS Stock Holding History

Delphia (USA)’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,078	Closed	-$270K	–	274
2022 Q3	$270K	Sell	12,078 -539	-4%	-$14K	0.31%	135
2022 Q2	$376K	Buy	+12,617	New	+$362K	0.26%	132

Other funds holding ALKS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return

CWM

CIBC World Markets New York $20.8B AUM

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Delphia (USA)'s ALKS Position: Q4 2022 in Review

Delphia (USA) sold out of Alkermes (ALKS) in Q4 2022, closing a stake of 12,078 shares — an estimated $270K sold.

Delphia (USA) first reported a position in ALKS in Q2 2022 and held it in 2 quarters. The position peaked at $376K in Q2 2022. 277 funds tracked by Wall St. Rank hold ALKS as of Q4 2022.

Delphia (USA) reported no remaining Alkermes position as of Q4 2022 after selling out during the quarter.
Delphia (USA) sold 12,078 Alkermes shares in Q4 2022, an estimated $270K.
Delphia (USA) first reported a position in Alkermes in Q2 2022 and held it in 2 quarters.
Delphia (USA)'s Alkermes position peaked at $376K in Q2 2022.
277 funds tracked by Wall St. Rank held Alkermes as of Q4 2022.

Based on Delphia (USA)'s 13F filing for Q4 2022, filed 14 Feb 2023.